VIKING THERAPEUTICS ($VKTX) posted quarterly earnings results on Wednesday, February 5th. The company reported earnings of -$0.32 per share, missing estimates of -$0.28 by $0.04. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $VKTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
VIKING THERAPEUTICS Insider Trading Activity
VIKING THERAPEUTICS insiders have traded $VKTX stock on the open market 34 times in the past 6 months. Of those trades, 0 have been purchases and 34 have been sales.
Here’s a breakdown of recent trading of $VKTX stock by insiders over the last 6 months:
- BRIAN LIAN (President & CEO) has made 0 purchases and 9 sales selling 524,490 shares for an estimated $31,118,561.
- GREG ZANTE (Chief Financial Officer) has made 0 purchases and 10 sales selling 181,996 shares for an estimated $12,239,758.
- J MATTHEW SINGLETON has made 0 purchases and 11 sales selling 68,786 shares for an estimated $4,576,469.
- MARIANNA MANCINI (Chief Operating Officer) has made 0 purchases and 2 sales selling 54,215 shares for an estimated $2,317,599.
- SARAH KATHRYN ROUAN sold 11,000 shares for an estimated $889,790
- LAWSON MACARTNEY sold 2,000 shares for an estimated $137,333
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
VIKING THERAPEUTICS Hedge Fund Activity
We have seen 233 institutional investors add shares of VIKING THERAPEUTICS stock to their portfolio, and 196 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PERPETUAL LTD removed 1,269,152 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $51,070,676
- CITADEL ADVISORS LLC added 1,006,198 shares (+215.7%) to their portfolio in Q3 2024, for an estimated $63,702,395
- PERCEPTIVE ADVISORS LLC added 978,610 shares (+135.7%) to their portfolio in Q3 2024, for an estimated $61,955,799
- MORGAN STANLEY added 927,638 shares (+97.9%) to their portfolio in Q3 2024, for an estimated $58,728,761
- GOLDMAN SACHS GROUP INC removed 917,481 shares (-85.4%) from their portfolio in Q3 2024, for an estimated $58,085,722
- BLACKROCK, INC. removed 645,808 shares (-10.7%) from their portfolio in Q3 2024, for an estimated $40,886,104
- VIKING GLOBAL INVESTORS LP removed 632,524 shares (-46.7%) from their portfolio in Q3 2024, for an estimated $40,045,094
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
